Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2012 Jun;78(12):4526–4528. doi: 10.1128/AEM.00348-12

High-Throughput Screening for Streptomyces Antibiotic Biosynthesis Activators

Li Chen a,b, Yemin Wang b, Hang Guo a,b, Min Xu b, Zixin Deng b, Meifeng Tao a,b,
PMCID: PMC3370547  PMID: 22504805

Abstract

A genomic cosmid library of Streptomyces clavuligerus was constructed and transferred efficiently by conjugation to Streptomyces lividans, and 12 distinct groups of overlapping cosmid clones that activated the silent actinorhodin biosynthesis gene cluster were identified. This generally applicable high-throughput screening procedure greatly facilitates the identification of antibiotic biosynthesis activators.

TEXT

The expression of secondary metabolic gene clusters in streptomycetes is controlled by regulatory genes, many of which are activators (2, 16, 24). Increasing the copy number of such activators often increases antibiotic production or activates silent gene clusters. This property of activators has been used for the cloning of abaA, afsQ1/Q2, afsR, and relA/spoT from Streptomyces coelicolor (6, 9, 10, 18) and afsR2 from Streptomyces lividans (25). Testing many clones for increased antibiotic biosynthesis is a major effort. We chose to generate a Streptomyces clavuligerus ATCC 27064 (NRRL3585) genomic library of 2,400 cosmids (average insert size of 33 kb, 10 genome equivalents) in Escherichia coli and then transfer the clones directly to S. lividans to test their ability to induce the near-silent actinorhodin (Act; blue type II aromatic polyketide) and calcium-dependent antibiotic (CDA; a colorless nonribosomal peptide). Here we describe a high-throughput procedure for transferring genomic cosmids individually from E. coli cultures grown in 96-well plates to S. lividans. Mass transfer from 96-well plates was used before, but the initial clones needed to be transferred to a suitable conjugation donor by transformation (17). We introduced the conjugative helper plasmid pUZ8002 into E. coli XL1-Blue MR (Stratagene) to produce strain XLUZ. pUZ8002 mobilizes oriT-plasmids efficiently from E. coli to streptomycetes (7). XLUZ was then used as the cloning host to construct the S. clavuligerus genomic library. We used pJTU2554, which is a 9.5-kb integrative (attP ϕC31) cos oriT vector, as the cloning vector (14). As a result, the clones of the genomic library could be mobilized into S. lividans directly, without an additional DNA transformation step (see below).

The E. coli strains containing the S. clavuligerus cosmids were grown in 100 μl LB broth for 6 h at 37°C in 96-well plates. About 105 heat-shocked spores of S. lividans 1326 (13) were added to each well and mixed. The 96-well plates were centrifuged, the liquid supernatant was removed, and about 3 μl from each pellet was transferred to a petri dish (diameter, 15 cm) with MS agar (8) using a 96-pin needle block. The plates were incubated at 30°C for 16 to 20 h and then flooded with 3 ml water containing antibiotics (apramycin to select for exconjugants and nalidixic acid to select against the E. coli donor). After 7 days of incubation at 30°C, apramycin-resistant S. lividans exconjugants were picked onto fresh MS plates containing the same antibiotics. From the 2,400 cosmid clones, 2,310 (96%) produced apramycin-resistant exconjugants. In total, we found 105 exconjugants (4%) that produced bluish pigment, indicating that the near-silent actinorhodin biosynthesis gene cluster of S. lividans had been activated by the introduced cosmid clones. All 105 cosmids were reintroduced individually into S. lividans by conjugation, and it was confirmed that antibiotic production was indeed caused by the presence of the cosmids and not by spontaneous mutations of the host.

Seventy-one antibiotic-activating cosmids were analyzed by terminal sequencing of the inserts and aligned with the S. clavuligerus genome sequence (20, 23). Forty-six of these cosmids overlapped, forming 12 contigs, and the remaining 25 were unique. Ten of the shared regions of these contigs encoded putative transcriptional regulators, some of which have well-characterized homologues in other streptomycetes, e.g., the two-component regulatory system PhoR-PhoP in contig 5 and the OsaB homologue (SCLAV_4638) and the ClgR homologue (SCLAV_4644) in contig 9 (Table 1) (1, 4, 22). In addition, all 14 cosmids of contig 1 contained the two genes SCLAV_3382 and SCLAV_3383, which encode putative proteins resembling the well-known antibiotic biosynthesis activators AfsR and AfsS. The SCLAV_3382 product was similar to AfsR of S. coelicolor (9) (69% amino acid [aa] identity) and to AfsR-p from Streptomyces peucetius (21) (74% aa identity). SCLAV_3383 encodes a 143-aa hypothetical protein that resembled the 63-aa AfsS of S. coelicolor (19) (46% identity in a 52-aa overlap). We therefore designated SCLAV_3382 and SCLAV_3383 afsRcla and afsScla, respectively.

Table 1.

Genes present in the overlapping regions of 12 contigs consisting of two or more cosmids that activated actinorhodin production in S. lividans

Contig No. of cosmids No. of bp of shared DNA Shared genes (no. of genes in overlap) Putative transcriptional regulator(s) encoded by the overlap DNA
1 14 5,531 SCLAV_3382-SCLAV_3383 (2) AfsRScla
2 6 15,689 SCLAV_5591-SCLAV_5602 (12) SCLAV_5602, a putative SRCAP-like transcriptional activatora
3 4 25,786 SCLAV_0066-SCLAV_0084 (19) SCLAV_0070, XRE family; SCLAV_0082, TetR family
4 4 10,563 SCLAV_2781-SCLAV_2787 (7) No regulator
5 3 16,679 SCLAV_3221-SCLAV_3233 (13) SCLAV_3221, PhoR (80% identity in a 415-aa overlap with PhoR of S. coelicolor [22]); SCLAV_3222, PhoP (84% identity in a 223-aa overlap with PhoP of S. coelicolor [22]); SCLAV_3224, CarD family
6 3 16,335 SCLAV_p1044-SCLAV_p1053 (10) No regulator
7 2 16,911 SCLAV_0411-SCLAV_0427 (17) SCLAV_0412, AfsR-like; SCLAV_0415, TetR family; SCLAV_0426, TetR family; SCLAV_0425, TetR family
8 2 28,726 SCLAV_2357-SCLAV_2375 (19) SCLAV_2362, sigma 24 homologue
9 2 26,644 SCLAV_4638-SCLAV_4654 (17) SCLAV_4638, OsaB (92% identity in a 222-aa overlap with OsaB of S. coelicolor [4]); SCLAV_4644, ClgR (90% identity in a 129-aa overlap with ClgR of S. lividans [1]); SCLAV_4650, AraC family
10 2 24,818 SCLAV_p0481-SCLAV_p0502 (22) SCLAV_p0483; SCLAV_p0499
11 2 30,540 SCLAV_p0593-SCLAV_p0621 (29) SCLAV_p0607; SCLAV_p0610, SARP familyb; SCLAV_p0620, TetR family
12 2 15,342 SCLAV_p1434-SCLAV_p1451 (18) SCLAV_p1438, two-component system sensor; SCLAV_p1439, two-component system response regulator
a

SRCAP, Snf2-related cAMP response-element binding protein (CREB)-binding protein (CBP) activator protein (12).

b

SARP, Streptomyces antibiotic regulatory protein.

To verify that afsRScla can promote actinorhodin production, a 4,423-bp BamHI-PvuII fragment, probably containing the native promoter and the coding sequences of afsRScla, was excised from cosmid 1G6 and cloned into the integrative vector pSET152 (3) to give pHL851. pHL851 was introduced by conjugation into S. lividans 1326 and produced exconjugants that were indistinguishable from S. lividans::1G6 with regard to actinorhodin production, while the wild-type S. lividans and the vector control S. lividans::pSET152 did not produce actinorhodin (Fig. 1a). This proved that the actinorhodin overproduction in S. lividans was caused by the heterologous expression of afsRScla.

Fig 1.

Fig 1

Actinorhodin and CDA production in S. lividans containing afsRScla expressed from the native promoter. (a) Actinorhodin (dark blue, showing as dark gray) production by S. lividans strains containing pHL851 or cosmid 1G6. The S. lividans wild-type and S. lividans::pSET152 controls did not produce actinorhodin. The MS agar plates were incubated for 6 days at 28°C and photographed. (b) Bioassay of CDA production. Agar plugs of S. lividans and S. lividans::pHL851 cultures (indicated at the top) were placed onto LB agar with or without Ca2+ (8 mM) that was spread with Bacillus mycoides. The plates were incubated for 12 h at 37°C. A 15-mm-diameter inhibition zone was observed with S. lividans::pHL851 on LB agar, and this zone increased to 23 mm on LB with Ca2+, a result which is characteristic for CDA. No inhibition zones were observed with the S. lividans wild type or the vector control. S. liv::pHL851, S. lividans containing pHL851 carrying afsRScla; S. liv::1G6, S. lividans containing the entire cosmid 1G6; S. liv::pSET152, S. lividans containing pSET152 (vector control); S. liv wt, S. lividans 1326 (wild type).

Calcium-dependent antibiotic (CDA) production was measured according to the procedure in reference 13. S. lividans and S. lividans::pHL851 were grown on nutrient agar (Oxoid), and agar plugs were placed onto LB agar with or without Ca2+ that had been preinoculated with Bacillus mycoides. After 12 h at 37°C, inhibition zones were observed with S. lividans::pHL851. The addition of Ca2+ increased the zone of inhibition, a result which is characteristic for CDA (Fig. 1b).

We also transferred pHL851 into S. clavuligerus. The strain was cultivated in shake flasks, and clavulanic acid production was analyzed according to the procedure in reference 11. Compared to the vector control, clavulanic acid production was increased 5-fold in S. clavuligerus::pHL851 (Fig. 2a). We were also surprised that S. clavuligerus::pHL851 growing on starch casein agar (15) was slightly yellow compared to the wild-type strain. The high-performance liquid chromatography (HPLC) analysis, UV-visible light (UV-Vis) spectrum (peaks at 246, 300, and 386 nm), and mass spectrum (Fig. 2b) were identical to those of a holomycin standard sample. Holomycin is a dithiolopyrrolone antibacterial and anticancer antibiotic produced by a special mutant of S. clavuligerus which was defective in late steps of clavulanic acid biosynthesis, but only minute quantities are synthesized by the wild-type strain (5). This indicated that increasing the copy number of afsRScla in S. clavuligerus also activated the normally silent holomycin biosynthetic gene cluster.

Fig 2.

Fig 2

An additional copy of afsRScla increased clavulanic acid production and induced holomycin production in S. clavuligerus. (a) Clavulanic acid production by S. clavuligerus::pHL851, S. clavuligerus::pSET152, and the wild-type strain, grown in shake flask cultures. Values are the means from three repeat cultures using the same clone, and the error bars show the standard deviations. (b) HPLC analysis (390-nm trace) of holomycin production (★) by S. clavuligerus::pHL851, cultivated for 4 days at 30°C on starch casein agar. The mass peaks typical for holomycin are shown in the inset box. S. cla::pHL851, S. clavuligerus::pHL851; S. cla::pSET152, vector control; wt, S. clavuligerus wild type.

These experiments have shown that a Streptomyces genomic cosmid library can be established in E. coli XLUZ containing a conjugative helper plasmid and that the resulting cosmid clones can be transferred to S. lividans with high efficiency from 96-well microtiter plates using a multiple inoculator. We have also shown that multiple groups of overlapping S. clavuligerus cosmid clones induced antibiotic production in S. lividans. Subcloning of the previously known regulatory genes afsRScla confirmed that the observed increase in antibiotic production was indeed caused by these two global antibiotic biosynthesis regulators.

ACKNOWLEDGMENTS

We thank Yi Yu for generously providing a sample of holomycin and Tobias Kieser for editing the manuscript.

This work was supported by the National Science Foundation of China, the Ministry of Science and Technology (863 and 973 Programs), the Ministry of Education, and the Shanghai Municipality.

Footnotes

Published ahead of print 13 April 2012

REFERENCES

  • 1. Bellier A, Mazodier P. 2004. ClgR, a novel regulator of clp and lon expression in Streptomyces. J. Bacteriol. 186:3238–3248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Bibb MJ. 2005. Regulation of secondary metabolism in streptomycetes. Curr. Opin. Microbiol. 8:208–215 [DOI] [PubMed] [Google Scholar]
  • 3. Bierman M, et al. 1992. Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene 116:43–49 [DOI] [PubMed] [Google Scholar]
  • 4. Bishop A, Fielding S, Dyson P, Herron P. 2004. Systematic insertional mutagenesis of a streptomycete genome: a link between osmoadaptation and antibiotic production. Genome Res. 14:893–900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. de la Fuente A, Lorenzana LM, Martín JF, Liras P. 2002. Mutants of Streptomyces clavuligerus with disruptions in different genes for clavulanic acid biosynthesis produce large amounts of holomycin: possible cross-regulation of two unrelated secondary metabolic pathways. J. Bacteriol. 184:6559–6565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Fernández-Moreno MA, et al. 1992. abaA, a new pleiotropic regulatory locus for antibiotic production in Streptomyces coelicolor. J. Bacteriol. 174:2958–2967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Flett F, Mersinias V, Smith CP. 1997. High efficiency intergeneric conjugal transfer of plasmid DNA from Escherichia coli to methyl DNA-restricting streptomycetes. FEMS Microbiol. Lett. 155:223–229 [DOI] [PubMed] [Google Scholar]
  • 8. Hobbs G, Frazer CM, Gardner DCJ, Cullum JA, Oliver SG. 1989. Dispersed growth of Streptomyces in liquid culture. Appl. Microbiol. Biotechnol. 31:272–277 [Google Scholar]
  • 9. Horinouchi S, Hara O, Beppu T. 1983. Cloning of a pleiotropic gene that positively controls biosynthesis of A-factor, actinorhodin, and prodigiosin in Streptomyces coelicolor A3(2) and Streptomyces lividans. J. Bacteriol. 155:1238–1248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ishizuka H, Horinouchi S, Kieser HM, Hopwood DA, Beppu T. 1992. A putative two-component regulatory system involved in secondary metabolism in Streptomyces spp. J. Bacteriol. 174:7585–7594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Jnawali HN, Lee HC, Sohng JK. 2010. Enhancement of clavulanic acid production by expressing regulatory genes in gap gene deletion mutant of Streptomyces clavuligerus NRRL3585. J. Microbiol. Biotechnol. 20:146–152 [PubMed] [Google Scholar]
  • 12. Johnston H, Kneer J, Chackalaparampil I, Yaciuk P, Chrivia J. 1999. Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein. J. Biol. Chem. 274:16370–16376 [DOI] [PubMed] [Google Scholar]
  • 13. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. 2000. Practical Streptomyces genetics. John Innes Foundation, Norwich, United Kingdom [Google Scholar]
  • 14. Li L, et al. 2008. The mildiomycin biosynthesis: initial steps for sequential generation of 5-hydroxymethylcytidine 5′-monophosphate and 5-hydroxymethylcytosine in Streptoverticillium rimofaciens ZJU5119. Chembiochem 9:1286–1294 [DOI] [PubMed] [Google Scholar]
  • 15. Liu CM, et al. 1979. X-14547A, a new ionophorous antibiotic produced by Streptomyces antibioticus NRRL 8167. Discovery, fermentation, biological properties and taxonomy of the producing culture. J. Antibiot. 32:95–99 [DOI] [PubMed] [Google Scholar]
  • 16. Martín JF, Liras P. 2010. Engineering of regulatory cascades and networks controlling antibiotic biosynthesis in Streptomyces. Curr. Opin. Microbiol. 13:263–273 [DOI] [PubMed] [Google Scholar]
  • 17. Martinez A, et al. 2004. Genetically modified bacterial strains and novel bacterial artificial chromosome shuttle vectors for constructing environmental libraries and detecting heterologous natural products in multiple expression hosts. Appl. Environ. Microbiol. 70:2452–2463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Martínez-Costa OH, et al. 1996. A relA/spoT homologous gene from Streptomyces coelicolor A3(2) controls antibiotic biosynthetic genes. J. Biol. Chem. 271:10627–10634 [DOI] [PubMed] [Google Scholar]
  • 19. Matsumoto A, Ishizuka H, Beppu T, Horinouchi S. 1995. Involvement of a small ORF downstream of the afsR gene in the regulation of secondary metabolism in Streptomyces coelicolor A3(2). Actinomycetologica 9:37–43 [Google Scholar]
  • 20. Medema MH, et al. 2010. The sequence of a 1.8-mb bacterial linear plasmid reveals a rich evolutionary reservoir of secondary metabolic pathways. Genome Biol. Evol. 2:212–224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Parajuli N, et al. 2005. Identification and characterization of the afsR homologue regulatory gene from Streptomyces peucetius ATCC 27952. Res. Microbiol. 156:707–712 [DOI] [PubMed] [Google Scholar]
  • 22. Sola-Landa A, Moura RS, Martín JF. 2003. The two-component PhoR-PhoP system controls both primary metabolism and secondary metabolite biosynthesis in Streptomyces lividans. Proc. Natl. Acad. Sci. U. S. A. 10:6133–6138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Song JY, et al. 2010. Draft genome sequence of Streptomyces clavuligerus NRRL 3585, a producer of diverse secondary metabolites. J. Bacteriol. 192:6317–6318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. van Wezel GP, McDowall KJ. 2011. The regulation of the secondary metabolism of Streptomyces: new links and experimental advances. Nat. Prod. Rep. 28:1311–1333 [DOI] [PubMed] [Google Scholar]
  • 25. Vogtli M, Chang PC, Cohen SN. 1994. afsR2: a previously undetected gene encoding a 63-amino-acid protein that stimulates antibiotic production in Streptomyces lividans. Mol. Microbiol. 14:643–653 [DOI] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES